Cáncer de endometrio de riesgo intermedio-una entidad clínica heterogénea

Endometrial cancer is the most common female genital tract neoplasm in the Western
world. In 2015, around 5,410 new cases were diagnosed in Spain, representing an incidence
of 5.9 per 100,000 women, with a 5-year prevalence of 7.6 per 100,000 [1]. Regarding world
incidence, presented in Figure 1, it is the sixth most common cancer in women (4.8% of
cancers in women) with an estimated incidence of 382,069 cases in 2018. The cumulative risk
of developing the disease at 75 years is 1.01% [2]. It is the 14th cancer in terms of mortality in
the world (89,929 deaths) [2]. The cumulative risk of death up to age 75 is 0.2%. In Spain the
mortality rate is estimated at 3.1 per 100,000 [1].
The increase in incidence of endometrial cancer in recent years in Europe and North
America is probably related to the older age of the population as well as the higher prevalence
of obesity and metabolic syndrome in these regions. Estimations show that the number of
cases will increase to 4,213 per 100,000 by 2030 in the United States [3]
[Madrid: 2021]

Compartir: